SCHEMBL21761341

SCHEMBL21761341

CC1CCN1C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OC[C@@H]1COCCO1

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 20/20 0.85
▸ ERBB2 P04626 20/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16405686 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16403245 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL20472867 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16402475 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16402474 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16403247 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL17821489 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16402472 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16403871 0.92 EGFR (1.00) EGFRERBB2
SCHEMBL16403869 0.92 EGFR (1.00) EGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022186-B1 QUINAZOLINE DERIVATIVES, COMPOSITIONS THEREOF, AND USE AS PHARMACEUTICALS SHANGHAI FOCHON PHARMACEUTICAL CO LTD (CN) 2020-02-26 — — EP disclosed
Send feedback